Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial

  1. Postel-Vinay, S.
  2. Coves, J.
  3. Texier, M.
  4. Aldea, M.
  5. Gazzah, A.
  6. Dómine, M.
  7. Planchard, D.
  8. De Las Peñas, R.
  9. Sala Gonzalez, M.A.
  10. Viteri, S.
  11. Perez, J.
  12. Ortega, A.L.
  13. Moran, T.
  14. Camps, C.
  15. Lopez-Martin, A.
  16. Provencio, M.
  17. Soria, J.-C.
  18. Besse, B.
  19. Massuti, B.
  20. Rosell, R.
Journal:
British Journal of Cancer

ISSN: 1532-1827 0007-0920

Year of publication: 2024

Volume: 130

Issue: 3

Pages: 417-424

Type: Article

DOI: 10.1038/S41416-023-02514-5 GOOGLE SCHOLAR

Sustainable development goals